Form 4: Dentsply Sirona Director Acquires Shares

Dentsply Sirona Director Jonathan Jay Mazelsky reported the acquisition of 10,000 shares of common stock.

Summary

• Jonathan Jay Mazelsky, a Director at Dentsply Sirona Inc., acquired 10,000 shares of common stock on June 12, 2026.
• The acquisition was made at a price of $10.14 per share.
• Following this transaction, Mazelsky beneficially owns 61,668.534 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing due to the director's acquisition of shares, which can signal confidence, but it lacks broader financial performance data.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The purchase of 10,000 shares indicates a direct investment by a key insider.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider stock purchases, particularly by directors, are often viewed positively by the market as they can indicate a belief in the company's intrinsic value and future performance within the dental technology and medical device industry.

Stakeholder Impact

• Shareholders may view this acquisition positively, interpreting it as a sign of insider confidence in the company's future value.
• Employees may also see this as a positive signal regarding the company's stability and growth potential.

Key Dates

Recommendation

The filing reports an insider purchase, which is generally a positive signal. However, without broader financial results or strategic updates, it's insufficient to warrant a strong buy or sell recommendation. A 'hold' reflects the neutral-to-positive sentiment derived solely from this insider transaction.

Keywords

Dentsply Sirona, XRAY, Form 4, Insider Trading, Stock Acquisition, Director, SEC Filing